Hiroyasu Yokomise Selected Research

xylometazoline (stas)

2/2022	Segmentectomy Provides Comparable Outcomes to Lobectomy for Stage IA Non-small Cell Lung Cancer with Spread through Air Spaces.
1/2022	Tumor-associated CD163+ macrophage as a predictor of tumor spread through air spaces and with CD25+ lymphocyte as a prognostic factor in resected stage I lung adenocarcinoma.
1/2022	Preoperative monocyte count is a predictor of recurrence after Stage I lung adenocarcinoma resection.
1/2021	Tumor-associated macrophage infiltration is associated with a higher rate of tumor spread through air spaces in resected lung adenocarcinomas.
1/2021	Current status and perspectives of spread through air spaces in lung cancer.
1/2021	The epithelial-mesenchymal transition phenotype is associated with the frequency of tumor spread through air spaces (STAS) and a High risk of recurrence after resection of lung carcinoma.
1/2019	Limited Resection Is Associated With a Higher Risk of Locoregional Recurrence than Lobectomy in Stage I Lung Adenocarcinoma With Tumor Spread Through Air Spaces.
8/2017	Tumor Spread Through Air Spaces Is an Independent Predictor of Recurrence-free Survival in Patients With Resected Lung Squamous Cell Carcinoma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Hiroyasu Yokomise Research Topics

Disease

48	Neoplasms (Cancer) 04/2022 - 04/2002
31	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 02/2022 - 06/2004
25	Lung Neoplasms (Lung Cancer) 02/2022 - 11/2002
11	Breast Neoplasms (Breast Cancer) 09/2019 - 04/2005
10	Squamous Cell Carcinoma (Epidermoid Carcinoma) 01/2022 - 04/2002
7	Adenocarcinoma of Lung 01/2022 - 08/2017
6	Adenocarcinoma 01/2022 - 04/2002
6	Carcinoma (Carcinomatosis) 01/2021 - 04/2002
6	Carcinogenesis 05/2012 - 04/2002
5	Hemorrhage 02/2017 - 01/2005
4	Pulmonary Emphysema 08/2022 - 12/2003
4	Empyema 09/2021 - 05/2009
4	Fistula 09/2021 - 11/2009
4	Emphysema 08/2014 - 10/2002
4	Neoplasm Metastasis (Metastasis) 12/2007 - 01/2004
3	Pathologic Processes 05/2012 - 01/2008
2	Pulmonary Hypertension 01/2021 - 11/2020
2	Lymphatic Metastasis 10/2018 - 08/2017
2	Atrial Fibrillation 02/2017 - 04/2015
2	Malignant Mesothelioma 12/2015 - 03/2004
2	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 03/2011 - 11/2003
2	Tracheomalacia 02/2004 - 01/2003
1	Lung Diseases (Lung Disease) 04/2022
1	Right Ventricular Hypertrophy 01/2021
1	Hypertrophy 01/2021
1	Vascular Remodeling 11/2020
1	Fever (Fevers) 10/2020
1	Febrile Neutropenia 12/2018
1	Infections 12/2018
1	Lipoma (Lipomata) 11/2018
1	Disease Progression 10/2018
1	Hypertension (High Blood Pressure) 01/2018
1	Proteinuria 01/2018

Drug/Important Bio-Agent (IBA)

10	Biomarkers (Surrogate Marker)IBA 01/2022 - 04/2006
8	xylometazoline (stas)IBA 02/2022 - 08/2017
6	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2018 - 06/2004
5	Pancreatic Elastase (Elastase)IBA 08/2022 - 12/2003
5	GelatinIBA 08/2022 - 01/2003
5	Carboplatin (JM8)FDA LinkGeneric 10/2018 - 04/2006
5	SurvivinIBA 05/2012 - 11/2005
4	Indocyanine Green (Cardio-Green)FDA LinkGeneric 01/2021 - 12/2007
4	TubulinIBA 01/2018 - 05/2010
4	taxaneIBA 01/2018 - 05/2007
3	Fibroblast Growth Factor 2 (Basic Fibroblast Growth Factor)IBA 12/2015 - 11/2009
3	Thymidylate SynthaseIBA 12/2013 - 04/2006
3	Glycoproteins (Glycoprotein)IBA 05/2012 - 01/2008
3	AntigensIBA 04/2007 - 12/2004
3	Biological ProductsIBA 02/2007 - 05/2005
2	SteroidsIBA 04/2022 - 05/2009
2	G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA 02/2020 - 07/2014
2	titanium silicide (TS-1)IBA 09/2019 - 01/2017
2	Paclitaxel (Taxol)FDA LinkGeneric 10/2018 - 01/2018
2	Bevacizumab (Avastin)FDA Link 01/2018 - 12/2015
2	PlatinumIBA 01/2017 - 03/2011
2	Cytotoxins (Cytolysins)IBA 06/2016 - 05/2014
2	Gemcitabine FDA Link 11/2015 - 04/2006
2	Ribonucleotide Reductases (Ribonucleotide Reductase)IBA 11/2015 - 04/2006
2	Hormones (Hormone)IBA 11/2014 - 03/2013
2	Messenger RNA (mRNA)IBA 07/2014 - 11/2003
2	Carcinoembryonic AntigenIBA 03/2012 - 06/2011
2	Deoxyglucose (2 Deoxy D glucose)IBA 07/2011 - 12/2006
2	ElementsIBA 04/2007 - 11/2002
2	ErbB Receptors (EGF Receptor)IBA 06/2006 - 04/2006
2	Proteins (Proteins, Gene)FDA Link 05/2006 - 11/2003
2	DNA (Deoxyribonucleic Acid)IBA 05/2006 - 02/2004
2	Bone Morphogenetic Proteins (Bone Morphogenetic Protein)IBA 02/2004 - 01/2003
1	Prednisolone (Predate)FDA LinkGeneric 04/2022
1	TinIBA 01/2022
1	Pharmaceutical PreparationsIBA 11/2021
1	MonocrotalineIBA 01/2021
1	monocrotaline pyrroleIBA 01/2021
1	Therapeutic UsesIBA 01/2021
1	CateninsIBA 01/2021
1	src-Family KinasesIBA 11/2020
1	Proto-Oncogene Proteins c-fynIBA 11/2020
1	Eicosapentaenoic AcidIBA 11/2020
1	Anaplastic Lymphoma KinaseIBA 01/2019
1	pegfilgrastim (Neulasta)FDA Link 12/2018
1	AnthracyclinesIBA 01/2018
1	Tissue Inhibitor of Metalloproteinase-1IBA 01/2018
1	Type II DNA Topoisomerases (Topoisomerase II)IBA 01/2018

Therapy/Procedure

21	Therapeutics 04/2022 - 11/2003
14	Drug Therapy (Chemotherapy) 12/2018 - 04/2002
11	Chemoradiotherapy 10/2018 - 05/2007
8	Thoracotomy 11/2018 - 10/2002
5	Segmental Mastectomy (Lumpectomy) 02/2022 - 01/2006
4	Pneumonectomy (Lung Volume Reduction) 02/2022 - 10/2002
4	Immunotherapy 11/2021 - 12/2004
4	Radiotherapy 11/2021 - 01/2004
3	Operative Surgical Procedures 09/2021 - 10/2012
2	Neoadjuvant Therapy 08/2020 - 09/2016
2	Traction 01/2016 - 06/2011
2	Microspheres (Microsphere) 08/2014 - 11/2008
2	Sutures (Suture) 04/2012 - 12/2011
2	Thyroidectomy 07/2005 - 03/2004
1	Aftercare (After-Treatment) 04/2022
1	Thoracostomy 09/2021
1	Curettage 10/2020
1	Secondary Prevention 12/2018
1	Consolidation Chemotherapy 10/2018